Clinical Trial Update: Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of EXPAREL administered into the TAP in cesarean section patients has been terminated; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Pain | Phase 4 | Status: TERMINATED | Results posted: 2016-06-28